Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia

ClinicalTrials.gov ID: NCT00626392

Public ClinicalTrials.gov record NCT00626392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-Blind, Parallel, Acetylsalicylic Acid (ASA) Run-In Study to Evaluate the EFFECTS of Acetylsalicylic Acid on Niaspan®-Induced Flushing in Subjects With Dyslipidemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study was to assess the effect of aspirin (ASA) on niacin extended-release (NER)-induced flushing in subjects with dyslipidemia.

Study identification

NCT ID: NCT00626392
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Abbott; Industry
Enrollment: 277 participants

Conditions and interventions

Conditions

Dyslipidemia

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 2008 (Type not available)
Primary completion: Apr 2008 (Actual)
Completion: Apr 2008 (Actual)
Last update posted: Sep 2, 2009

2008

United States locations

U.S. sites: 26
U.S. states: 11
U.S. cities: 25

Facility	City	State	ZIP	Site status
Not listed	Huntsville	Alabama	35801	—
Not listed	Scottsdale	Arizona	85251	—
Not listed	Tucson	Arizona	85710	—
Not listed	Tucson	Arizona	85712	—
Not listed	Anaheim	California	92801	—
Not listed	Los Angeles	California	90057	—
Not listed	Newport Beach	California	92660	—
Not listed	Stockton	California	95204	—
Not listed	Vista	California	90057	—
Not listed	Westlake Village	California	91361	—
Not listed	Coral Gables	Florida	33134	—
Not listed	Jacksonville	Florida	32259	—
Not listed	Miami	Florida	33186	—
Not listed	Pembroke Pines	Florida	33027	—
Not listed	West Palm Beach	Florida	33407	—
Not listed	North Dartmouth	Massachusetts	02747	—
Not listed	Rochester	New York	14609	—
Not listed	Charlotte	North Carolina	28262	—
Not listed	Winston-Salem	North Carolina	27103	—
Not listed	Penndel	Pennsylvania	19047	—
Not listed	Johnston	Rhode Island	02919	—
Not listed	Mt. Pleasant	South Carolina	29464	—
Not listed	Simpsonville	South Carolina	29681	—
Not listed	Colleyville	Texas	76034	—
Not listed	Houston	Texas	77074	—
Not listed	San Antonio	Texas	78229	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00626392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 2, 2009 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00626392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →